Femasys Inc. (FEMY) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
2.90
↓-19% vs avg
5yr avg: 3.55
30Y Low0.7·High10.6
ROE
↓
-455.8%
↑-175% vs avg
5yr avg: -165.6%
30Y Low-456%·High-50%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
FEMY Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Femasys Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $13M | $23M | $24M | $15M | $11M | $46M | — | — |
| Enterprise Value | $8M | $18M | $28M | $-15428 | $-1794473 | $22M | — | — |
| P/E Ratio → | -0.91 | — | — | — | — | — | — | — |
| P/S Ratio | 5.52 | 9.93 | 15.04 | 13.99 | 8.81 | 39.02 | — | — |
| P/B Ratio | 2.90 | 3.88 | 10.63 | 0.82 | 0.70 | 1.75 | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
FEMY EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 7.94 | 17.49 | -0.01 | -1.49 | 18.86 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
FEMY Profitability
Margins and return-on-capital ratios measuring operating efficiency
Femasys Inc. earns an operating margin of -767.0%. Operating margins have expanded from -1353.4% to -767.0% over the past 3 years, signaling improving operational efficiency. A negative ROE of -455.8% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.0% | 62.0% | 66.6% | 64.5% | 63.4% | 68.6% | 70.5% | 75.9% |
| Operating Margin | -767.0% | -767.0% | -1091.8% | -1353.4% | -961.7% | -706.7% | -668.0% | -1252.6% |
| Net Profit Margin | -812.3% | -812.3% | -1155.0% | -1329.1% | -944.6% | -639.0% | -666.2% | -1213.3% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -455.8% | -455.8% | -182.2% | -84.8% | -54.8% | -50.5% | -196.0% | — |
| ROA | -112.3% | -112.3% | -93.6% | -63.8% | -50.1% | -41.7% | -68.3% | -89.1% |
| ROIC | -347.4% | -347.4% | -277.0% | -353.2% | -324.4% | -260.5% | -229.9% | — |
| ROCE | -167.9% | -167.9% | -124.5% | -72.4% | -54.9% | -52.8% | -86.2% | -102.4% |
FEMY Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $9M exceeds total debt of $5M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.80 | 0.80 | 3.23 | 0.37 | 0.04 | 0.04 | 0.58 | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.78 | 1.73 | -0.82 | -0.81 | -0.90 | -0.36 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — |
| Interest Coverage | -8.85 | -8.85 | -10.73 | -85.12 | -844.80 | -390.86 | -549.72 | -1129.06 |
Net cash position: cash ($9M) exceeds total debt ($5M)
FEMY Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Femasys Inc.'s current ratio of 4.53x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.95x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 7.59x to 4.53x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.53 | 4.53 | 0.93 | 7.59 | 9.25 | 15.15 | 1.34 | 6.25 |
| Quick Ratio | 2.95 | 2.95 | 0.58 | 7.37 | 8.96 | 15.02 | 1.29 | 6.12 |
| Cash Ratio | 2.55 | 2.55 | 0.40 | 7.11 | 8.48 | 14.65 | 1.15 | 5.77 |
| Asset Turnover | — | 0.11 | 0.13 | 0.04 | 0.07 | 0.04 | 0.14 | 0.07 |
| Inventory Turnover | 0.15 | 0.15 | 0.18 | 0.57 | 1.01 | 1.78 | 2.33 | 1.30 |
| Days Sales Outstanding | — | 98.14 | 109.42 | 33.68 | 23.44 | 26.07 | 44.24 | 32.83 |
FEMY Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Femasys Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $40M | $22M | $15M | $12M | $12M | $12M | $12M |
Peer Comparison
Compare FEMY with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 FEMYYou | $13M | -0.9 | — | — | 62.0% | -767.0% | -455.8% | -347.4% | — |
 CODA | $136M | 32.7 | 18.3 | 22.6 | 66.5% | 17.1% | 7.4% | 11.2% | 0.1 |
 BLFS | $1B | -88.2 | — | 101.2 | 64.6% | -12.6% | -3.4% | -2.8% | — |
 XWEL | $8M | -0.3 | — | — | 22.7% | -32.0% | — | -124.8% | — |
 HOLO | $3M | -0.3 | — | — | 22.5% | -47.6% | -7.3% | -27.3% | — |
 SSKN | $6M | -0.6 | — | — | 56.9% | -27.6% | -114.2% | -38.9% | — |
 TELA | $41M | -0.8 | — | — | 67.1% | -49.2% | -159.9% | -151.6% | — |
 NXRT | $760M | -23.8 | 18.6 | 9.1 | 84.3% | 11.1% | -8.9% | 1.1% | 12.6 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 BDX | $54B | 25.6 | 14.4 | 20.3 | 45.4% | 11.8% | 6.5% | 4.3% | 3.8 |
 COO | $12B | 32.1 | 13.0 | 27.1 | 60.7% | 16.7% | 4.6% | 4.8% | 2.5 |
| Healthcare Median | — | 22.2 | 14.4 | 18.6 | 64.0% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
See FEMY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FEMY Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare FEMY vs CODA
Side-by-side business, growth, and profitability comparison vs Coda Octopus Group, Inc..
Start ComparisonFEMY — Frequently Asked Questions
Quick answers to the most common questions about buying FEMY stock.
What is Femasys Inc.'s P/E ratio?
Femasys Inc.'s current P/E ratio is -0.9x. This places it at the 50th percentile of its historical range.
What is Femasys Inc.'s ROE?
Femasys Inc.'s return on equity (ROE) is -455.8%. The historical average is -170.7%.
Is FEMY stock overvalued?
Based on historical data, Femasys Inc. is trading at a P/E of -0.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Femasys Inc.'s profit margins?
Femasys Inc. has 62.0% gross margin and -767.0% operating margin.